

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.38914588 |
| 2 | ensheathment of neurons (GO:0007272) | 6.68028319 |
| 3 | axon ensheathment (GO:0008366) | 6.68028319 |
| 4 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.67837836 |
| 5 | myelination (GO:0042552) | 6.67038462 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.31690087 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.90618568 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.90618568 |
| 9 | myelin maintenance (GO:0043217) | 5.87833895 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.79134682 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.48362316 |
| 12 | amyloid precursor protein metabolic process (GO:0042982) | 5.48197805 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.44149712 |
| 14 | cholesterol biosynthetic process (GO:0006695) | 5.42924756 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.26874907 |
| 16 | response to methylmercury (GO:0051597) | 5.16974827 |
| 17 | negative regulation of neurotransmitter transport (GO:0051589) | 5.08582207 |
| 18 | sterol biosynthetic process (GO:0016126) | 4.93285880 |
| 19 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.87858787 |
| 20 | negative regulation of protein localization to cell surface (GO:2000009) | 4.86119556 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.84954172 |
| 22 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.75051874 |
| 23 | isoprenoid biosynthetic process (GO:0008299) | 4.62874968 |
| 24 | establishment of mitochondrion localization (GO:0051654) | 4.61536519 |
| 25 | regulation of lipoprotein metabolic process (GO:0050746) | 4.48416806 |
| 26 | response to lipoprotein particle (GO:0055094) | 4.43834854 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 4.33667753 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 4.33667753 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.33667753 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.33667753 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.33667753 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 4.33667753 |
| 33 | regulation of collateral sprouting (GO:0048670) | 4.29833563 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.24111412 |
| 35 | creatine metabolic process (GO:0006600) | 4.16146699 |
| 36 | detection of other organism (GO:0098543) | 4.16055923 |
| 37 | amyloid precursor protein catabolic process (GO:0042987) | 4.13454668 |
| 38 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.08201898 |
| 39 | L-amino acid import (GO:0043092) | 4.07399456 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.98207139 |
| 41 | detection of bacterium (GO:0016045) | 3.96167147 |
| 42 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.94328963 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92557178 |
| 44 | eye photoreceptor cell differentiation (GO:0001754) | 3.91335134 |
| 45 | photoreceptor cell differentiation (GO:0046530) | 3.91335134 |
| 46 | glycerophospholipid catabolic process (GO:0046475) | 3.90412153 |
| 47 | GPI anchor biosynthetic process (GO:0006506) | 3.85746988 |
| 48 | oligodendrocyte differentiation (GO:0048709) | 3.81737876 |
| 49 | response to interleukin-15 (GO:0070672) | 3.78506017 |
| 50 | import into cell (GO:0098657) | 3.78335274 |
| 51 | apical protein localization (GO:0045176) | 3.74774194 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 3.72075345 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.70269169 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.69759538 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67783198 |
| 56 | asymmetric protein localization (GO:0008105) | 3.65609325 |
| 57 | activated T cell proliferation (GO:0050798) | 3.65535908 |
| 58 | leukocyte aggregation (GO:0070486) | 3.65250906 |
| 59 | GPI anchor metabolic process (GO:0006505) | 3.60823391 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58678961 |
| 61 | astrocyte development (GO:0014002) | 3.58189639 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.56753197 |
| 63 | negative thymic T cell selection (GO:0045060) | 3.54861004 |
| 64 | neutrophil activation (GO:0042119) | 3.52231799 |
| 65 | negative T cell selection (GO:0043383) | 3.51383499 |
| 66 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.43352068 |
| 67 | cellular extravasation (GO:0045123) | 3.41693917 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.39035896 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.38962189 |
| 70 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.38726176 |
| 71 | response to type I interferon (GO:0034340) | 3.35917352 |
| 72 | neuron remodeling (GO:0016322) | 3.34906992 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.34697174 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.34697174 |
| 75 | response to redox state (GO:0051775) | 3.34501251 |
| 76 | presynaptic membrane organization (GO:0097090) | 3.30905016 |
| 77 | very long-chain fatty acid metabolic process (GO:0000038) | 3.30665535 |
| 78 | axon development (GO:0061564) | 3.30338885 |
| 79 | protein neddylation (GO:0045116) | 3.29624050 |
| 80 | regulation of tolerance induction (GO:0002643) | 3.29276093 |
| 81 | protein palmitoylation (GO:0018345) | 3.29172779 |
| 82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.28011864 |
| 83 | membrane tubulation (GO:0097320) | 3.27531527 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 3.27447796 |
| 85 | response to peptidoglycan (GO:0032494) | 3.27325944 |
| 86 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.26437276 |
| 87 | granulocyte activation (GO:0036230) | 3.24590764 |
| 88 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.23998025 |
| 89 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.23418217 |
| 90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.22524901 |
| 91 | positive regulation of glial cell differentiation (GO:0045687) | 3.21505727 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20526810 |
| 93 | regulation of B cell differentiation (GO:0045577) | 3.20236560 |
| 94 | membrane raft organization (GO:0031579) | 3.19938377 |
| 95 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.19937442 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19475079 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 3.18994794 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.17169156 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.17169156 |
| 100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17138409 |
| 101 | response to host immune response (GO:0052572) | 3.17138409 |
| 102 | magnesium ion transport (GO:0015693) | 3.15554234 |
| 103 | substantia nigra development (GO:0021762) | 3.12806500 |
| 104 | glycosylceramide metabolic process (GO:0006677) | 3.12460713 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 3.12142765 |
| 106 | tissue regeneration (GO:0042246) | 3.11866333 |
| 107 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09602707 |
| 108 | detection of biotic stimulus (GO:0009595) | 3.09445195 |
| 109 | positive T cell selection (GO:0043368) | 3.09434381 |
| 110 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05117321 |
| 111 | response to host (GO:0075136) | 3.05117321 |
| 112 | response to host defenses (GO:0052200) | 3.05117321 |
| 113 | response to muramyl dipeptide (GO:0032495) | 3.02999451 |
| 114 | positive regulation of gliogenesis (GO:0014015) | 3.01775987 |
| 115 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.01657874 |
| 116 | microglial cell activation (GO:0001774) | 3.01494570 |
| 117 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.99930012 |
| 118 | neutrophil activation involved in immune response (GO:0002283) | 2.98198525 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.97862316 |
| 120 | limb bud formation (GO:0060174) | 2.97346984 |
| 121 | regulation of regulatory T cell differentiation (GO:0045589) | 2.97097566 |
| 122 | myeloid cell activation involved in immune response (GO:0002275) | 2.96085850 |
| 123 | dendritic cell chemotaxis (GO:0002407) | 2.96030718 |
| 124 | T cell migration (GO:0072678) | 2.95102667 |
| 125 | dendritic cell migration (GO:0036336) | 2.94867193 |
| 126 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.93285865 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.93114768 |
| 128 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.90472146 |
| 129 | positive regulation of pseudopodium assembly (GO:0031274) | 2.90452434 |
| 130 | amino acid import (GO:0043090) | 2.90134671 |
| 131 | respiratory burst (GO:0045730) | 2.89485001 |
| 132 | organ growth (GO:0035265) | 2.88652969 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86497899 |
| 134 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.85423572 |
| 135 | B cell receptor signaling pathway (GO:0050853) | 2.85289850 |
| 136 | negative regulation of chemokine production (GO:0032682) | 2.84811983 |
| 137 | NIK/NF-kappaB signaling (GO:0038061) | 2.84553146 |
| 138 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.84198922 |
| 139 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82593532 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.82518341 |
| 141 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.81948075 |
| 142 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.80126313 |
| 143 | regulation of leukocyte degranulation (GO:0043300) | 2.80080813 |
| 144 | T cell selection (GO:0045058) | 2.79270260 |
| 145 | thymic T cell selection (GO:0045061) | 2.79265065 |
| 146 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78280997 |
| 147 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76519474 |
| 148 | positive regulation of B cell differentiation (GO:0045579) | 2.74322644 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.74235473 |
| 150 | tolerance induction (GO:0002507) | 2.73413551 |
| 151 | neurotransmitter uptake (GO:0001504) | 2.73284734 |
| 152 | germinal center formation (GO:0002467) | 2.72923374 |
| 153 | defense response to protozoan (GO:0042832) | 2.72786573 |
| 154 | positive regulation of interleukin-17 production (GO:0032740) | 2.70982103 |
| 155 | adult walking behavior (GO:0007628) | 2.70505015 |
| 156 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70244923 |
| 157 | extracellular matrix assembly (GO:0085029) | 2.69981031 |
| 158 | nerve growth factor signaling pathway (GO:0038180) | 2.69357601 |
| 159 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.68670723 |
| 160 | macrophage activation (GO:0042116) | 2.68549915 |
| 161 | myelination in peripheral nervous system (GO:0022011) | 2.68474968 |
| 162 | peripheral nervous system axon ensheathment (GO:0032292) | 2.68474968 |
| 163 | adhesion of symbiont to host cell (GO:0044650) | 2.68268312 |
| 164 | virion attachment to host cell (GO:0019062) | 2.68268312 |
| 165 | B cell mediated immunity (GO:0019724) | 2.66268845 |
| 166 | positive regulation of mast cell activation (GO:0033005) | 2.65141137 |
| 167 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63770664 |
| 168 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63082205 |
| 169 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.61929021 |
| 170 | positive regulation of granulocyte differentiation (GO:0030854) | 2.61660959 |
| 171 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.61548087 |
| 172 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.61548087 |
| 173 | regulation of cell killing (GO:0031341) | 2.60988256 |
| 174 | regulation of necroptotic process (GO:0060544) | 2.60875683 |
| 175 | regulation of mast cell activation (GO:0033003) | 2.60870876 |
| 176 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.60345047 |
| 177 | microtubule polymerization or depolymerization (GO:0031109) | 2.59852647 |
| 178 | leukocyte degranulation (GO:0043299) | 2.58758967 |
| 179 | mannosylation (GO:0097502) | 2.57817264 |
| 180 | negative regulation of JUN kinase activity (GO:0043508) | 2.57008298 |
| 181 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.56735923 |
| 182 | presynaptic membrane assembly (GO:0097105) | 2.56613134 |
| 183 | enteric nervous system development (GO:0048484) | 2.55826860 |
| 184 | Golgi to endosome transport (GO:0006895) | 2.55279715 |
| 185 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.53398915 |
| 186 | heme transport (GO:0015886) | 2.52708237 |
| 187 | regulation of pseudopodium assembly (GO:0031272) | 2.51369402 |
| 188 | iron coordination entity transport (GO:1901678) | 2.50933482 |
| 189 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.50813637 |
| 190 | negative regulation of acute inflammatory response (GO:0002674) | 2.50290881 |
| 191 | nucleotide transmembrane transport (GO:1901679) | 2.50235891 |
| 192 | glial cell development (GO:0021782) | 2.50116093 |
| 193 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.50004723 |
| 194 | alcohol biosynthetic process (GO:0046165) | 2.49963714 |
| 195 | thioester biosynthetic process (GO:0035384) | 2.49733779 |
| 196 | acyl-CoA biosynthetic process (GO:0071616) | 2.49733779 |
| 197 | regulation of somitogenesis (GO:0014807) | 2.49723215 |
| 198 | central nervous system myelination (GO:0022010) | 12.9502590 |
| 199 | axon ensheathment in central nervous system (GO:0032291) | 12.9502590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89009903 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.27232533 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.78941589 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.24765590 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07267653 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95462731 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81082080 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76087454 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.75108756 |
| 10 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.65733732 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58263085 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.53546849 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42510452 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40122933 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35047749 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.33530267 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26767428 |
| 18 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25693551 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.21958829 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19508349 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.17136657 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.14209285 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10495633 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08574510 |
| 25 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07407979 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.06386916 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05445418 |
| 28 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.04875052 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01808357 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01400792 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01290636 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92206652 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.91552969 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88240028 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.87260832 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86742804 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.84137107 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.84132297 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83458354 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83269250 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83108546 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81692722 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76959232 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76702573 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76638987 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76424936 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74436943 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.73827040 |
| 49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70548661 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.70289191 |
| 51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69271032 |
| 52 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67495203 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63965592 |
| 54 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.61928338 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60804228 |
| 56 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59288289 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58406615 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54160465 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53939840 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.53586634 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.52890858 |
| 62 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.51555513 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51083974 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48760561 |
| 65 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48664896 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48664896 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47466529 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46690238 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46690238 |
| 70 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.45859814 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45312922 |
| 72 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.44730833 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44718376 |
| 74 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44505272 |
| 75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.39088659 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38636665 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38081307 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37360718 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37114026 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36426305 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 1.34148721 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33969604 |
| 83 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.33333031 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31773144 |
| 85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31472622 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30712160 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30236978 |
| 88 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.29292496 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28992061 |
| 90 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.28299624 |
| 91 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26427908 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25960759 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.25187725 |
| 94 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25182858 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24803677 |
| 96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.24746093 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23474116 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23451819 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 1.23315478 |
| 100 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.22934845 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22911691 |
| 102 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22885116 |
| 103 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.22756694 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22400016 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22282655 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22190957 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21511197 |
| 108 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20653575 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20581099 |
| 110 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18759110 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16194285 |
| 112 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15834196 |
| 113 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.15636474 |
| 114 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15561514 |
| 115 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.14939133 |
| 116 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14484588 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14033462 |
| 118 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13894051 |
| 119 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13020088 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12952124 |
| 121 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12035342 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10894422 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10730270 |
| 124 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10545178 |
| 125 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.10078473 |
| 126 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10044742 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09990183 |
| 128 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09304866 |
| 129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08675210 |
| 130 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08580075 |
| 131 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07982788 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07777732 |
| 133 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07401716 |
| 134 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07078690 |
| 135 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06719808 |
| 136 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06601024 |
| 137 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06546288 |
| 138 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05113629 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04042619 |
| 140 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02501957 |
| 141 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02445195 |
| 142 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02220168 |
| 143 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02220168 |
| 144 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01857861 |
| 145 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01443043 |
| 146 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01332187 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00705850 |
| 148 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00694635 |
| 149 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.00543629 |
| 150 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00067817 |
| 151 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00045497 |
| 152 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99978781 |
| 153 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99506686 |
| 154 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98297911 |
| 155 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98271436 |
| 156 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.98179141 |
| 157 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97633039 |
| 158 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97167271 |
| 159 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97071944 |
| 160 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96928710 |
| 161 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96372560 |
| 162 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96234850 |
| 163 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95123938 |
| 164 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.95067426 |
| 165 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94615831 |
| 166 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94303800 |
| 167 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94201133 |
| 168 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93358892 |
| 169 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93069499 |
| 170 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92760261 |
| 171 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91080882 |
| 172 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90353184 |
| 173 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89277705 |
| 174 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89120553 |
| 175 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89074056 |
| 176 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88919637 |
| 177 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88865997 |
| 178 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88071197 |
| 179 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87872581 |
| 180 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.87660159 |
| 181 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87232407 |
| 182 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.87101876 |
| 183 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86893604 |
| 184 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86136495 |
| 185 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83599731 |
| 186 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83136257 |
| 187 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82014541 |
| 188 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81057873 |
| 189 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79806714 |
| 190 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79396309 |
| 191 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78730091 |
| 192 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77406371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 6.18585666 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.50091179 |
| 3 | MP0003436_decreased_susceptibility_to | 3.98633337 |
| 4 | MP0003690_abnormal_glial_cell | 3.43189032 |
| 5 | MP0003303_peritoneal_inflammation | 3.09517953 |
| 6 | MP0003880_abnormal_central_pattern | 2.88099462 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.75116553 |
| 8 | MP0001800_abnormal_humoral_immune | 2.69883874 |
| 9 | MP0004742_abnormal_vestibular_system | 2.69760554 |
| 10 | MP0005025_abnormal_response_to | 2.67544892 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.66613754 |
| 12 | MP0001529_abnormal_vocalization | 2.62588636 |
| 13 | MP0003329_amyloid_beta_deposits | 2.61421955 |
| 14 | MP0005171_absent_coat_pigmentation | 2.58953414 |
| 15 | MP0001905_abnormal_dopamine_level | 2.52005646 |
| 16 | MP0003136_yellow_coat_color | 2.48738537 |
| 17 | MP0000685_abnormal_immune_system | 2.47475538 |
| 18 | MP0002723_abnormal_immune_serum | 2.41137817 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.40481443 |
| 20 | MP0005409_darkened_coat_color | 2.39978786 |
| 21 | MP0001819_abnormal_immune_cell | 2.39906114 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.35893287 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.34950463 |
| 24 | MP0003634_abnormal_glial_cell | 2.30898206 |
| 25 | MP0004270_analgesia | 2.26913378 |
| 26 | MP0006082_CNS_inflammation | 2.15649566 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.15143663 |
| 28 | MP0003866_abnormal_defecation | 2.14595208 |
| 29 | MP0005451_abnormal_body_composition | 2.13909009 |
| 30 | MP0001486_abnormal_startle_reflex | 2.13093948 |
| 31 | MP0008260_abnormal_autophagy | 2.12707877 |
| 32 | MP0010678_abnormal_skin_adnexa | 2.08366270 |
| 33 | MP0002272_abnormal_nervous_system | 2.07591213 |
| 34 | MP0005464_abnormal_platelet_physiology | 2.05601879 |
| 35 | MP0004142_abnormal_muscle_tone | 2.04823111 |
| 36 | MP0004885_abnormal_endolymph | 1.99351714 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.99176294 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.98815785 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.96947313 |
| 40 | MP0002405_respiratory_system_inflammati | 1.95349552 |
| 41 | MP0005410_abnormal_fertilization | 1.94676573 |
| 42 | MP0003632_abnormal_nervous_system | 1.89154962 |
| 43 | MP0000383_abnormal_hair_follicle | 1.88544637 |
| 44 | MP0003828_pulmonary_edema | 1.88407540 |
| 45 | MP0001346_abnormal_lacrimal_gland | 1.87935265 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.82548623 |
| 47 | MP0000716_abnormal_immune_system | 1.80045957 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.79876562 |
| 49 | MP0002398_abnormal_bone_marrow | 1.79242342 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.76600327 |
| 51 | MP0004134_abnormal_chest_morphology | 1.75639009 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.69314075 |
| 53 | MP0000778_abnormal_nervous_system | 1.67561241 |
| 54 | MP0003631_nervous_system_phenotype | 1.67449308 |
| 55 | MP0000604_amyloidosis | 1.66244723 |
| 56 | MP0004947_skin_inflammation | 1.65629966 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.63528425 |
| 58 | MP0005423_abnormal_somatic_nervous | 1.60351428 |
| 59 | MP0002229_neurodegeneration | 1.60098631 |
| 60 | MP0004381_abnormal_hair_follicle | 1.57663548 |
| 61 | MP0003633_abnormal_nervous_system | 1.56897958 |
| 62 | MP0002064_seizures | 1.55899160 |
| 63 | MP0004043_abnormal_pH_regulation | 1.53779664 |
| 64 | MP0000858_altered_metastatic_potential | 1.46421023 |
| 65 | MP0001851_eye_inflammation | 1.45005447 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.44665090 |
| 67 | MP0003448_altered_tumor_morphology | 1.42658349 |
| 68 | MP0002429_abnormal_blood_cell | 1.42088465 |
| 69 | MP0001958_emphysema | 1.41743949 |
| 70 | MP0002722_abnormal_immune_system | 1.41153831 |
| 71 | MP0000462_abnormal_digestive_system | 1.38284467 |
| 72 | MP0008469_abnormal_protein_level | 1.35034800 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.33998473 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.33079160 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 1.31344679 |
| 76 | MP0000490_abnormal_crypts_of | 1.29736227 |
| 77 | MP0004883_abnormal_blood_vessel | 1.29217783 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 1.28510406 |
| 79 | MP0006054_spinal_hemorrhage | 1.28319762 |
| 80 | MP0009764_decreased_sensitivity_to | 1.26486181 |
| 81 | MP0003091_abnormal_cell_migration | 1.23339981 |
| 82 | MP0003172_abnormal_lysosome_physiology | 1.22476650 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.22092536 |
| 84 | MP0000566_synostosis | 1.21722071 |
| 85 | MP0001348_abnormal_lacrimal_gland | 1.20465060 |
| 86 | MP0001963_abnormal_hearing_physiology | 1.16589361 |
| 87 | MP0001873_stomach_inflammation | 1.16418927 |
| 88 | MP0001663_abnormal_digestive_system | 1.16418222 |
| 89 | MP0000647_abnormal_sebaceous_gland | 1.15927351 |
| 90 | MP0009278_abnormal_bone_marrow | 1.15095857 |
| 91 | MP0003279_aneurysm | 1.14199615 |
| 92 | MP0005166_decreased_susceptibility_to | 1.13459372 |
| 93 | MP0005623_abnormal_meninges_morphology | 1.13147713 |
| 94 | MP0002148_abnormal_hypersensitivity_rea | 1.12806788 |
| 95 | MP0003724_increased_susceptibility_to | 1.12170884 |
| 96 | MP0009046_muscle_twitch | 1.11621918 |
| 97 | MP0005390_skeleton_phenotype | 1.10817476 |
| 98 | MP0003195_calcinosis | 1.10181942 |
| 99 | MP0008438_abnormal_cutaneous_collagen | 1.07474022 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 1.06774711 |
| 101 | MP0002132_abnormal_respiratory_system | 1.06743149 |
| 102 | MP0005023_abnormal_wound_healing | 1.03516853 |
| 103 | MP0002006_tumorigenesis | 1.01390669 |
| 104 | MP0009840_abnormal_foam_cell | 1.01190348 |
| 105 | MP0000955_abnormal_spinal_cord | 1.00679456 |
| 106 | MP0002277_abnormal_respiratory_mucosa | 0.98596721 |
| 107 | MP0005195_abnormal_posterior_eye | 0.98518458 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 0.98241032 |
| 109 | MP0000249_abnormal_blood_vessel | 0.97350789 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.96741510 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.95433244 |
| 112 | MP0004147_increased_porphyrin_level | 0.95126609 |
| 113 | MP0002882_abnormal_neuron_morphology | 0.93992204 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.92725133 |
| 115 | MP0002066_abnormal_motor_capabilities/c | 0.92105489 |
| 116 | MP0000343_altered_response_to | 0.91690005 |
| 117 | MP0009745_abnormal_behavioral_response | 0.91129344 |
| 118 | MP0003075_altered_response_to | 0.90776842 |
| 119 | MP0001970_abnormal_pain_threshold | 0.90568824 |
| 120 | MP0005408_hypopigmentation | 0.90468511 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.88499062 |
| 122 | MP0002933_joint_inflammation | 0.88358085 |
| 123 | MP0003938_abnormal_ear_development | 0.88011004 |
| 124 | MP0002419_abnormal_innate_immunity | 0.87792154 |
| 125 | MP0005387_immune_system_phenotype | 0.87108009 |
| 126 | MP0001790_abnormal_immune_system | 0.87108009 |
| 127 | MP0004808_abnormal_hematopoietic_stem | 0.87077148 |
| 128 | MP0003937_abnormal_limbs/digits/tail_de | 0.86963320 |
| 129 | MP0000579_abnormal_nail_morphology | 0.86757191 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.84690916 |
| 131 | MP0003045_fibrosis | 0.83127247 |
| 132 | MP0008569_lethality_at_weaning | 0.82730595 |
| 133 | MP0009763_increased_sensitivity_to | 0.82274554 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.80639967 |
| 135 | MP0005000_abnormal_immune_tolerance | 0.80144733 |
| 136 | MP0009250_abnormal_appendicular_skeleto | 0.79737479 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.78736561 |
| 138 | MP0005397_hematopoietic_system_phenotyp | 0.78736561 |
| 139 | MP0005379_endocrine/exocrine_gland_phen | 0.78591653 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.78402257 |
| 141 | MP0003705_abnormal_hypodermis_morpholog | 0.78120250 |
| 142 | MP0000372_irregular_coat_pigmentation | 0.77995044 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.77948501 |
| 144 | MP0001835_abnormal_antigen_presentation | 0.76422972 |
| 145 | MP0002133_abnormal_respiratory_system | 0.76115553 |
| 146 | MP0005388_respiratory_system_phenotype | 0.76115553 |
| 147 | MP0002572_abnormal_emotion/affect_behav | 0.75650364 |
| 148 | MP0005381_digestive/alimentary_phenotyp | 0.75088479 |
| 149 | MP0005310_abnormal_salivary_gland | 0.73729200 |
| 150 | MP0003635_abnormal_synaptic_transmissio | 0.73608595 |
| 151 | MP0004510_myositis | 0.73145442 |
| 152 | MP0003795_abnormal_bone_structure | 0.72724323 |
| 153 | MP0001177_atelectasis | 0.71227799 |
| 154 | MP0002163_abnormal_gland_morphology | 0.70926163 |
| 155 | MP0002067_abnormal_sensory_capabilities | 0.70472175 |
| 156 | MP0000015_abnormal_ear_pigmentation | 0.69096969 |
| 157 | MP0005671_abnormal_response_to | 0.68094689 |
| 158 | MP0002938_white_spotting | 0.68032629 |
| 159 | MP0000026_abnormal_inner_ear | 0.67804314 |
| 160 | MP0001440_abnormal_grooming_behavior | 0.67733106 |
| 161 | MP0001664_abnormal_digestion | 0.67695484 |
| 162 | MP0005164_abnormal_response_to | 0.67657763 |
| 163 | MP0009785_altered_susceptibility_to | 0.67100155 |
| 164 | MP0002139_abnormal_hepatobiliary_system | 0.66862978 |
| 165 | MP0000477_abnormal_intestine_morphology | 0.65738618 |
| 166 | MP0004924_abnormal_behavior | 0.65078495 |
| 167 | MP0005386_behavior/neurological_phenoty | 0.65078495 |
| 168 | MP0000747_muscle_weakness | 0.63065778 |
| 169 | MP0001986_abnormal_taste_sensitivity | 0.60186329 |
| 170 | MP0002877_abnormal_melanocyte_morpholog | 0.59943050 |
| 171 | MP0002136_abnormal_kidney_physiology | 0.57874737 |
| 172 | MP0010368_abnormal_lymphatic_system | 0.57841210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.90632965 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.90632965 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.67319953 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.58580952 |
| 5 | Parakeratosis (HP:0001036) | 5.43326102 |
| 6 | Myositis (HP:0100614) | 5.29282707 |
| 7 | Orchitis (HP:0100796) | 4.91465116 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.80848594 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.63054591 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.62491013 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 4.55257160 |
| 12 | Peripheral hypomyelination (HP:0007182) | 4.50676546 |
| 13 | Optic neuritis (HP:0100653) | 4.50062791 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.50062791 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.46592041 |
| 16 | Onion bulb formation (HP:0003383) | 4.15951193 |
| 17 | T lymphocytopenia (HP:0005403) | 3.99281851 |
| 18 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.95244960 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.85829962 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.83509022 |
| 21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.81694572 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.63043547 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.54868664 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.49952573 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.49402717 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 3.48808221 |
| 27 | Sensory axonal neuropathy (HP:0003390) | 3.32794731 |
| 28 | Insidious onset (HP:0003587) | 3.30159926 |
| 29 | Termporal pattern (HP:0011008) | 3.30159926 |
| 30 | Encephalitis (HP:0002383) | 3.28069712 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.25554980 |
| 32 | Peritonitis (HP:0002586) | 3.25318398 |
| 33 | Abnormal auditory evoked potentials (HP:0006958) | 3.24892689 |
| 34 | Meningitis (HP:0001287) | 3.19673185 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.16421019 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.13620904 |
| 37 | Retinal dysplasia (HP:0007973) | 3.11271149 |
| 38 | Recurrent skin infections (HP:0001581) | 3.10167509 |
| 39 | Cerebral hypomyelination (HP:0006808) | 3.08453602 |
| 40 | Axonal loss (HP:0003447) | 3.08451124 |
| 41 | Gingivitis (HP:0000230) | 3.07389870 |
| 42 | Spastic gait (HP:0002064) | 3.06632731 |
| 43 | Increased serum pyruvate (HP:0003542) | 3.05396917 |
| 44 | Abnormality of glycolysis (HP:0004366) | 3.05396917 |
| 45 | Cerebral hemorrhage (HP:0001342) | 3.04502070 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98298710 |
| 47 | Obstructive lung disease (HP:0006536) | 2.98298710 |
| 48 | Vasculitis (HP:0002633) | 2.97446398 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.97107978 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.94760037 |
| 51 | Chest pain (HP:0100749) | 2.93463847 |
| 52 | Stridor (HP:0010307) | 2.91178772 |
| 53 | Leukodystrophy (HP:0002415) | 2.90165168 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.88839086 |
| 55 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.87100284 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86548447 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86548447 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.86065667 |
| 59 | Alacrima (HP:0000522) | 2.85058980 |
| 60 | Pustule (HP:0200039) | 2.84579129 |
| 61 | Hypoplastic pelvis (HP:0008839) | 2.81329945 |
| 62 | Abnormality of T cells (HP:0002843) | 2.81113621 |
| 63 | Slow saccadic eye movements (HP:0000514) | 2.78448221 |
| 64 | Hemoptysis (HP:0002105) | 2.77591988 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.75767888 |
| 66 | Ankle clonus (HP:0011448) | 2.75211238 |
| 67 | Absent septum pellucidum (HP:0001331) | 2.72515563 |
| 68 | Leukocytosis (HP:0001974) | 2.71763817 |
| 69 | Autoamputation (HP:0001218) | 2.70540546 |
| 70 | Anteriorly placed anus (HP:0001545) | 2.69670289 |
| 71 | Increased IgE level (HP:0003212) | 2.64600060 |
| 72 | Recurrent viral infections (HP:0004429) | 2.64047734 |
| 73 | Dysmetria (HP:0001310) | 2.63989563 |
| 74 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.62964175 |
| 75 | Intention tremor (HP:0002080) | 2.62794513 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.61059699 |
| 77 | Epistaxis (HP:0000421) | 2.59315477 |
| 78 | Scanning speech (HP:0002168) | 2.56509305 |
| 79 | Premature skin wrinkling (HP:0100678) | 2.56240334 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 2.56145686 |
| 81 | Arterial thrombosis (HP:0004420) | 2.54916665 |
| 82 | Malnutrition (HP:0004395) | 2.53609296 |
| 83 | Gingival bleeding (HP:0000225) | 2.52449143 |
| 84 | Loss of speech (HP:0002371) | 2.51679881 |
| 85 | Increased IgM level (HP:0003496) | 2.48000731 |
| 86 | Urticaria (HP:0001025) | 2.47535267 |
| 87 | Cellulitis (HP:0100658) | 2.47415795 |
| 88 | Pulmonary embolism (HP:0002204) | 2.45951287 |
| 89 | White forelock (HP:0002211) | 2.41958769 |
| 90 | Patchy hypopigmentation of hair (HP:0011365) | 2.41520723 |
| 91 | Autoimmune hemolytic anemia (HP:0001890) | 2.40145403 |
| 92 | Episodic fever (HP:0001954) | 2.34885364 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 2.34158444 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 2.31076616 |
| 95 | Abnormality of the septum pellucidum (HP:0007375) | 2.29865721 |
| 96 | Hypoplasia of the iris (HP:0007676) | 2.29224908 |
| 97 | Morphological abnormality of the inner ear (HP:0011390) | 2.27272523 |
| 98 | Metabolic alkalosis (HP:0200114) | 2.26542274 |
| 99 | Petechiae (HP:0000967) | 2.25730124 |
| 100 | Partial duplication of thumb phalanx (HP:0009944) | 2.25665568 |
| 101 | Foot dorsiflexor weakness (HP:0009027) | 2.25021362 |
| 102 | Recurrent bronchitis (HP:0002837) | 2.24049290 |
| 103 | Thickened helices (HP:0000391) | 2.23738874 |
| 104 | Chronic diarrhea (HP:0002028) | 2.22898489 |
| 105 | Colitis (HP:0002583) | 2.22894125 |
| 106 | Granulocytopenia (HP:0001913) | 2.22516452 |
| 107 | Glomerulopathy (HP:0100820) | 2.22375188 |
| 108 | Spondylolisthesis (HP:0003302) | 2.21394460 |
| 109 | Absent frontal sinuses (HP:0002688) | 2.21311573 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21174983 |
| 111 | Clumsiness (HP:0002312) | 2.21049404 |
| 112 | Pheochromocytoma (HP:0002666) | 2.20651438 |
| 113 | Viral hepatitis (HP:0006562) | 2.20042199 |
| 114 | Spastic tetraparesis (HP:0001285) | 2.19820640 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 2.18460646 |
| 116 | Decreased lacrimation (HP:0000633) | 2.17595300 |
| 117 | Autoimmune thrombocytopenia (HP:0001973) | 2.16274015 |
| 118 | Split foot (HP:0001839) | 2.12820951 |
| 119 | Abnormality of macrophages (HP:0004311) | 2.11935221 |
| 120 | Myokymia (HP:0002411) | 2.11906280 |
| 121 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.10433719 |
| 122 | Abnormality of the pleura (HP:0002103) | 2.09712882 |
| 123 | Coronal craniosynostosis (HP:0004440) | 2.08433897 |
| 124 | CNS hypomyelination (HP:0003429) | 2.07732227 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 2.07664171 |
| 126 | Dilatation of the ascending aorta (HP:0005111) | 2.07649474 |
| 127 | Hematochezia (HP:0002573) | 2.06458114 |
| 128 | Methylmalonic acidemia (HP:0002912) | 2.06082689 |
| 129 | Eosinophilia (HP:0001880) | 2.04529907 |
| 130 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.03285349 |
| 131 | Aplasia of the phalanges of the hand (HP:0009802) | 2.03285349 |
| 132 | Aplasia involving bones of the extremities (HP:0009825) | 2.03285349 |
| 133 | Renal Fanconi syndrome (HP:0001994) | 2.02371465 |
| 134 | Peripheral demyelination (HP:0011096) | 2.01886999 |
| 135 | Periodontitis (HP:0000704) | 2.01742645 |
| 136 | Hemiplegia (HP:0002301) | 2.01292098 |
| 137 | Hypophosphatemic rickets (HP:0004912) | 2.00945543 |
| 138 | Anomalous pulmonary venous return (HP:0010772) | 2.00133585 |
| 139 | Abnormal platelet volume (HP:0011876) | 2.00072225 |
| 140 | Increased circulating renin level (HP:0000848) | 1.99863934 |
| 141 | Muscle fiber splitting (HP:0003555) | 1.99540361 |
| 142 | Cupped ear (HP:0000378) | 1.99424810 |
| 143 | Panhypogammaglobulinemia (HP:0003139) | 1.99261470 |
| 144 | Anorexia (HP:0002039) | 1.99176150 |
| 145 | Abnormality of the foot musculature (HP:0001436) | 1.99170849 |
| 146 | Decreased motor nerve conduction velocity (HP:0003431) | 1.99165230 |
| 147 | Stomatitis (HP:0010280) | 1.98734760 |
| 148 | Lower limb muscle weakness (HP:0007340) | 1.98589123 |
| 149 | Amyloidosis (HP:0011034) | 1.98276897 |
| 150 | Duplicated collecting system (HP:0000081) | 1.98130954 |
| 151 | Nasal polyposis (HP:0100582) | 1.97895910 |
| 152 | Abnormality of T cell physiology (HP:0011840) | 1.97768199 |
| 153 | Osteomyelitis (HP:0002754) | 1.97246801 |
| 154 | 3-Methylglutaconic aciduria (HP:0003535) | 1.96508662 |
| 155 | Hypokalemic alkalosis (HP:0001949) | 1.93467529 |
| 156 | Partial duplication of the phalanx of hand (HP:0009999) | 1.92941649 |
| 157 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90395568 |
| 158 | Neuroendocrine neoplasm (HP:0100634) | 1.88544567 |
| 159 | Adrenal hypoplasia (HP:0000835) | 1.88425651 |
| 160 | Hyperactive renin-angiotensin system (HP:0000841) | 1.87976384 |
| 161 | Urinary incontinence (HP:0000020) | 1.87283257 |
| 162 | Abolished electroretinogram (ERG) (HP:0000550) | 1.86838490 |
| 163 | Interstitial pulmonary disease (HP:0006530) | 1.85087543 |
| 164 | Erythroderma (HP:0001019) | 1.84058354 |
| 165 | Osteolytic defects of the hand bones (HP:0009699) | 1.83045866 |
| 166 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83045866 |
| 167 | Esophageal atresia (HP:0002032) | 1.82874863 |
| 168 | Abnormality of the pericardium (HP:0001697) | 1.82251222 |
| 169 | Infantile muscular hypotonia (HP:0008947) | 1.81673076 |
| 170 | Abnormality of the pulmonary veins (HP:0011718) | 1.81351379 |
| 171 | Gangrene (HP:0100758) | 1.80647639 |
| 172 | Abnormality of eosinophils (HP:0001879) | 1.80570640 |
| 173 | Papilledema (HP:0001085) | 1.80243871 |
| 174 | Duplication of thumb phalanx (HP:0009942) | 1.80057351 |
| 175 | Hypomagnesemia (HP:0002917) | 1.79685664 |
| 176 | Stomach cancer (HP:0012126) | 1.79119468 |
| 177 | Polygenic inheritance (HP:0010982) | 1.78563722 |
| 178 | Poor speech (HP:0002465) | 1.78403361 |
| 179 | Aortic dissection (HP:0002647) | 1.77863088 |
| 180 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77720762 |
| 181 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.77128385 |
| 182 | Progressive neurologic deterioration (HP:0002344) | 1.76769505 |
| 183 | Lymphopenia (HP:0001888) | 1.76351050 |
| 184 | Stenosis of the external auditory canal (HP:0000402) | 1.76267394 |
| 185 | Abnormality of the renal collecting system (HP:0004742) | 1.75525931 |
| 186 | Chronic otitis media (HP:0000389) | 1.75353887 |
| 187 | Gowers sign (HP:0003391) | 1.75283815 |
| 188 | Skin ulcer (HP:0200042) | 1.74435940 |
| 189 | Agammaglobulinemia (HP:0004432) | 1.71990498 |
| 190 | Septo-optic dysplasia (HP:0100842) | 1.71783801 |
| 191 | Abnormality of oral frenula (HP:0000190) | 1.71336179 |
| 192 | Bowel incontinence (HP:0002607) | 1.69163367 |
| 193 | Spastic paraparesis (HP:0002313) | 1.67514017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.28170833 |
| 2 | EPHB1 | 4.41983198 |
| 3 | OXSR1 | 4.08801914 |
| 4 | MAPKAPK5 | 3.74836424 |
| 5 | RIPK4 | 3.68958801 |
| 6 | MAP4K1 | 3.65183514 |
| 7 | PBK | 3.45202640 |
| 8 | PKN1 | 2.91444612 |
| 9 | ERN1 | 2.80016342 |
| 10 | TYK2 | 2.75573428 |
| 11 | TXK | 2.70259517 |
| 12 | FES | 2.58597483 |
| 13 | BCR | 2.56312992 |
| 14 | WNK4 | 2.41425863 |
| 15 | ZAP70 | 2.32949679 |
| 16 | MET | 2.14805349 |
| 17 | TAOK3 | 2.11019741 |
| 18 | JAK3 | 2.06831185 |
| 19 | GRK6 | 1.97275759 |
| 20 | MAP2K3 | 1.95051608 |
| 21 | TESK2 | 1.92033674 |
| 22 | FGFR2 | 1.90813443 |
| 23 | CLK1 | 1.79519316 |
| 24 | WNK1 | 1.78556134 |
| 25 | IKBKE | 1.76984658 |
| 26 | CDK19 | 1.70407307 |
| 27 | LIMK1 | 1.68610565 |
| 28 | TBK1 | 1.64180503 |
| 29 | CSNK1A1L | 1.59765615 |
| 30 | FGR | 1.59087182 |
| 31 | BTK | 1.55831368 |
| 32 | CSNK1G3 | 1.55556678 |
| 33 | KIT | 1.55085242 |
| 34 | MAP3K3 | 1.48967879 |
| 35 | JAK1 | 1.48930991 |
| 36 | SYK | 1.47887032 |
| 37 | MST4 | 1.45604562 |
| 38 | UHMK1 | 1.44215533 |
| 39 | MUSK | 1.43691125 |
| 40 | TNK2 | 1.43639330 |
| 41 | HCK | 1.40397023 |
| 42 | MAP3K11 | 1.37906066 |
| 43 | CAMK2B | 1.37510160 |
| 44 | BMPR1B | 1.34880456 |
| 45 | RIPK1 | 1.31663590 |
| 46 | ROCK2 | 1.29929528 |
| 47 | NEK6 | 1.28388442 |
| 48 | NTRK1 | 1.27488263 |
| 49 | DYRK2 | 1.27430257 |
| 50 | SGK223 | 1.27247558 |
| 51 | SGK494 | 1.27247558 |
| 52 | TGFBR2 | 1.25392302 |
| 53 | PNCK | 1.24246660 |
| 54 | CSNK1G1 | 1.19852871 |
| 55 | IRAK1 | 1.17772651 |
| 56 | LYN | 1.16806046 |
| 57 | TESK1 | 1.16319552 |
| 58 | CASK | 1.15763652 |
| 59 | MAP3K1 | 1.15026197 |
| 60 | TAOK1 | 1.13393413 |
| 61 | PTK6 | 1.06657410 |
| 62 | CAMK2D | 1.06522056 |
| 63 | CSNK1G2 | 1.03542321 |
| 64 | BLK | 1.02923906 |
| 65 | ACVR1B | 1.00682479 |
| 66 | STK10 | 1.00588228 |
| 67 | RPS6KA5 | 0.98310808 |
| 68 | TEC | 0.95789909 |
| 69 | JAK2 | 0.94502230 |
| 70 | PRKG2 | 0.92769529 |
| 71 | MST1R | 0.92302884 |
| 72 | PRKCQ | 0.90359492 |
| 73 | KDR | 0.88730508 |
| 74 | PIK3CG | 0.88333137 |
| 75 | GRK1 | 0.88003075 |
| 76 | CDC42BPA | 0.87382693 |
| 77 | CAMK2G | 0.86008738 |
| 78 | PRKD1 | 0.83965912 |
| 79 | LRRK2 | 0.82699662 |
| 80 | MATK | 0.82071205 |
| 81 | MAPK7 | 0.81182739 |
| 82 | FGFR3 | 0.78797053 |
| 83 | MAP3K14 | 0.78397931 |
| 84 | MAPK15 | 0.78148229 |
| 85 | YES1 | 0.77995850 |
| 86 | MAP2K2 | 0.77603848 |
| 87 | TRPM7 | 0.76692970 |
| 88 | MARK2 | 0.75198658 |
| 89 | PDK1 | 0.74579392 |
| 90 | CAMK2A | 0.74520523 |
| 91 | FGFR4 | 0.73751298 |
| 92 | BMPR2 | 0.73412569 |
| 93 | IRAK3 | 0.72995690 |
| 94 | STK38 | 0.71286965 |
| 95 | MKNK1 | 0.70718428 |
| 96 | PRKCE | 0.70280472 |
| 97 | NLK | 0.68948228 |
| 98 | MAP3K13 | 0.68518095 |
| 99 | PDGFRB | 0.66939837 |
| 100 | TRIB3 | 0.66773723 |
| 101 | TTN | 0.66376059 |
| 102 | GRK7 | 0.65880585 |
| 103 | SMG1 | 0.64002770 |
| 104 | ADRBK2 | 0.62326282 |
| 105 | PIM1 | 0.60486035 |
| 106 | PAK6 | 0.60322489 |
| 107 | TAOK2 | 0.60046516 |
| 108 | ERBB4 | 0.59507628 |
| 109 | CSF1R | 0.56347222 |
| 110 | HIPK2 | 0.56217425 |
| 111 | GSK3A | 0.53937849 |
| 112 | MAP3K7 | 0.52969683 |
| 113 | TIE1 | 0.51526795 |
| 114 | CDK14 | 0.50638307 |
| 115 | DYRK1B | 0.50156434 |
| 116 | MARK3 | 0.49983973 |
| 117 | PAK3 | 0.49829855 |
| 118 | LMTK2 | 0.49725017 |
| 119 | CDK5 | 0.49575539 |
| 120 | PDPK1 | 0.47770003 |
| 121 | PRKG1 | 0.47503061 |
| 122 | MOS | 0.45893221 |
| 123 | CSNK1D | 0.45840084 |
| 124 | IKBKB | 0.45482888 |
| 125 | IRAK4 | 0.44901243 |
| 126 | ARAF | 0.44256245 |
| 127 | CDK6 | 0.43680362 |
| 128 | MAP3K10 | 0.43228487 |
| 129 | CDK15 | 0.43104516 |
| 130 | MAP4K2 | 0.43072703 |
| 131 | CSNK1A1 | 0.43042412 |
| 132 | RET | 0.42711863 |
| 133 | MAP3K2 | 0.42294549 |
| 134 | DMPK | 0.42213931 |
| 135 | FYN | 0.41914466 |
| 136 | MAPK11 | 0.41909595 |
| 137 | LCK | 0.39472134 |
| 138 | BMX | 0.38686719 |
| 139 | CAMKK2 | 0.38452115 |
| 140 | ITK | 0.38062029 |
| 141 | MAPKAPK2 | 0.37915928 |
| 142 | SIK3 | 0.37811653 |
| 143 | CDK18 | 0.37557769 |
| 144 | ABL2 | 0.37346077 |
| 145 | CDK11A | 0.36965168 |
| 146 | ICK | 0.36209802 |
| 147 | TNIK | 0.35837369 |
| 148 | PAK1 | 0.35799154 |
| 149 | IRAK2 | 0.35396190 |
| 150 | EPHA3 | 0.34953011 |
| 151 | PRKACB | 0.34743365 |
| 152 | MARK1 | 0.34320812 |
| 153 | CAMK1G | 0.34119422 |
| 154 | PIK3CA | 0.33987091 |
| 155 | EPHA2 | 0.33609163 |
| 156 | NUAK1 | 0.32293985 |
| 157 | RPS6KC1 | 0.31980631 |
| 158 | RPS6KL1 | 0.31980631 |
| 159 | STK24 | 0.31955324 |
| 160 | PRPF4B | 0.31735374 |
| 161 | CSK | 0.31586699 |
| 162 | PRKD2 | 0.31573479 |
| 163 | PHKG2 | 0.31389568 |
| 164 | PHKG1 | 0.31389568 |
| 165 | PINK1 | 0.31352982 |
| 166 | MELK | 0.31019130 |
| 167 | ABL1 | 0.30707501 |
| 168 | PTK2B | 0.30182664 |
| 169 | KSR2 | 0.30084231 |
| 170 | MAPK13 | 0.29109266 |
| 171 | DAPK3 | 0.26685141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.86393873 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.17113748 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.97102028 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.30010890 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.14787789 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.09966770 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70503756 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48426443 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43516918 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.36853547 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.08051101 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.05162061 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.03515153 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.03313642 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96709033 |
| 16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.84394795 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83674395 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81321625 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80546518 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72332930 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.71230829 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70933941 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.67899883 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.64907820 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64355895 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64034374 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61617851 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59183365 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55190532 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50113331 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.50006382 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45849748 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44869208 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44205289 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43643131 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.39171373 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31556172 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.28573217 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28529844 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28005473 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27984420 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24405203 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22951150 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21042989 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19201073 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.16997598 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14716932 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.14291395 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.11955528 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11112341 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.08737780 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 1.06491443 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.05792639 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05751997 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05190552 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03599265 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03595478 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03346443 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03093162 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 1.02938450 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02737562 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00728999 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.00330093 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99550679 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99540153 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98474147 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98074010 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95719102 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94930285 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.90980947 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89904868 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86924347 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.85250633 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.83820571 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83751812 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82317865 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81974009 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75766861 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.74990174 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73964196 |
| 81 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72695961 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71904493 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.71124298 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70672976 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70388368 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69666580 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.69206971 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67700658 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67546072 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.67370791 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66937001 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64522484 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64003348 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62427695 |
| 95 | Morphine addiction_Homo sapiens_hsa05032 | 0.61617983 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59809204 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59747581 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56618778 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56217812 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56056578 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55976278 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55810076 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55340984 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55115135 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.54751113 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53715193 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53403606 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53205194 |
| 109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53012676 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52529593 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52397097 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52161593 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52080269 |
| 114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.51802097 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51185854 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50771464 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50515010 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.49904717 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49004589 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48841980 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48725104 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48686701 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47758458 |
| 124 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46548574 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45776558 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.45642083 |
| 127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43285239 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42553838 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42430303 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.42391090 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.41706159 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41522088 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41285233 |
| 134 | Peroxisome_Homo sapiens_hsa04146 | 0.40547684 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40328167 |
| 136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39846633 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39824942 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39770054 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39751619 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39734568 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.39342585 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38512901 |
| 143 | Phototransduction_Homo sapiens_hsa04744 | 0.38434138 |
| 144 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38339900 |
| 145 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37746245 |
| 146 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35975751 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35271992 |
| 148 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34583967 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34449194 |
| 150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34090146 |
| 151 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33300525 |
| 152 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33162117 |
| 153 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.31482656 |
| 154 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30448217 |
| 155 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30315025 |
| 156 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28909793 |
| 157 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28747711 |
| 158 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28414327 |
| 159 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28400647 |
| 160 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27162497 |
| 161 | Salivary secretion_Homo sapiens_hsa04970 | 0.23950584 |
| 162 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23845925 |
| 163 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23529983 |
| 164 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20751577 |
| 165 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20412234 |
| 166 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20314566 |
| 167 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19157696 |
| 168 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.18713379 |

